CKW Financial Group’s Biogen BIIB Stock Holding History

CKW Financial Group’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$18K	Hold	100	–	–	﹤0.01%	91
2025 Q4	$18K	Hold	100	–	–	﹤0.01%	99
2025 Q3	$15K	Hold	100	–	–	﹤0.01%	109
2025 Q2	$13K	Hold	100	–	–	﹤0.01%	109
2025 Q1	$13K	Hold	100	–	–	﹤0.01%	115
2024 Q4	$15K	Hold	100	–	–	﹤0.01%	173
2024 Q3	$19K	Hold	100	–	–	﹤0.01%	164
2024 Q2	$23K	Hold	100	–	–	﹤0.01%	158
2024 Q1	$21K	Hold	100	–	–	﹤0.01%	162
2023 Q4	$26K	Hold	100	–	–	﹤0.01%	163
2023 Q3	$26K	Hold	100	–	–	﹤0.01%	151
2023 Q2	$28K	Hold	100	–	–	﹤0.01%	149
2023 Q1	$28K	Hold	100	–	–	﹤0.01%	135
2022 Q4	$28K	Hold	100	–	–	﹤0.01%	138
2022 Q3	$27K	Hold	100	–	–	0.01%	137
2022 Q2	$21K	Hold	100	–	–	﹤0.01%	148
2022 Q1	$21K	Buy	+100	New	+$21.7K	﹤0.01%	149

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CKW Financial Group's BIIB Position: Q1 2026 in Review

CKW Financial Group held its Biogen (BIIB) position steady in Q1 2026 at 100 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #91.

CKW Financial Group first reported a position in BIIB in Q1 2022 and has held it in 17 quarters since. The position peaked at $28K in Q2 2023. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

CKW Financial Group held 100 shares of Biogen worth $18K as of Q1 2026.
CKW Financial Group left its Biogen share count unchanged in Q1 2026.
Biogen made up ﹤0.01% of CKW Financial Group's portfolio in Q1 2026, its #91 holding.
CKW Financial Group first reported a position in Biogen in Q1 2022 and has held it in 17 quarters since.
CKW Financial Group's Biogen position peaked at $28K in Q2 2023.
1,003 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on CKW Financial Group's 13F filing for Q1 2026, filed 7 May 2026.